December 3, 2021

Moderna’s Covid-19 Vaccine Works Safely in Adolescents, Company Says

Moderna Inc.

MRNA 1.84%

said its Covid-19 vaccine was effective in children aged 12 to 17 in a new study, a finding that could clear the way for a second shot for use in adolescents.

The Cambridge, Mass., company said the vaccine induced immune responses among children that were comparable to those seen in a study of adults last year.

Also, there were no cases of symptomatic Covid-19 among vaccine recipients, Moderna said, suggesting 100% vaccine efficacy in adolescents, though overall very few among the 3,700 children in the study got sick.

Based on the results, Moderna said it plans in early June to request that regulators in the U.S. and other countries authorize the use of its vaccine in children aged 12 to 17 years.

The U.S. Food and Drug Administration could make a decision within weeks of the request if it follows the same kind of timetable if took with

Pfizer Inc.’s

PFE -0.64%

shot. The agency took about a month to clear Pfizer’s request for use of its Covid-19 vaccine in adolescents.

U.S. regulatory clearance would add a second choice in Covid-19 vaccines for adolescents. Immunizing children is crucial, health specialists say, to developing the communitywide immunity needed to move fully past pandemic precautions.

In December, the Covid-19 vaccine from Pfizer and its partner

BioNTech

SE was cleared for 16- and 17-year-olds, along with adults. Earlier this month, the FDA authorized the Pfizer shot for use in children aged 12 to 15 years.

More than 5 million adolescents aged 12 to 17 years have received at least one dose of a Covid-19 vaccine so far, according to the Centers for Disease Control and Prevention Director

Rochelle Walensky.

The FDA authorized use of Moderna’s shot in people 18 years and older in December.

Expanded use of Moderna’s shot could bolster plans to hold summer camps for children and ease the return of full-time, in-person instruction in middle and high schools in the fall.

As more U.S. adults get their Covid-19 vaccines, a variety of side effects are emerging. WSJ’s Daniela Hernandez speaks with an infectious disease specialist on what is common, what isn’t and when to seek medical attention. Photo: Associated Press

“We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents,” Moderna Chief Executive Stéphane Bancel said, referring to the vaccine’s code name.

Moderna and Pfizer have also begun testing their vaccines in younger children. Results are expected later in the year.

Children generally have a lower risk of severe Covid-19 symptoms than older adults, but some have been hospitalized and a small number have died from it.

Moderna started its Phase 2/3 study in adolescents in December. About two-thirds of the children in the study were given two doses of its vaccine, four weeks apart, while the rest received a placebo.

About four weeks after the second dose, researchers took blood samples from study subjects and measured the levels of neutralizing antibodies, which are components of the immune system that can block the coronavirus from replicating.

The antibody levels among vaccinated adolescents were comparable with those from adults who had participated in a separate Phase 3 study of the vaccine in adults. The adult study had shown that the vaccine was 94.1% effective at preventing symptomatic Covid-19.

There were four cases of Covid-19 among adolescents who received the placebo, versus zero cases among those getting the vaccine, starting 14 days after the second dose, Moderna said.

The vaccine was 93% effective after the first dose, using a different set of criteria that included milder cases, Moderna said.

The company said the most common side effects include injection-site pain, headache and fatigue.

Write to Peter Loftus at peter.loftus@wsj.com

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related Posts

SEC to Review Market Structure as Meme Stocks Stir Frenzy

June 9, 2021

June 9, 2021

The Securities and Exchange Commission is considering changes to some of the stock market’s most fundamental rules in light of...

Covid-19 Aid to Concert Halls, Theaters Set to Be Distributed Next Week

May 21, 2021

May 21, 2021

WASHINGTON—The Small Business Administration is aiming to start awarding Covid-19 aid to concert halls, theaters and other live-entertainment venues early...

Apple’s Moves to Tighten Flow of User Data Leave Advertisers Anxious

June 8, 2021

June 8, 2021

Digital advertisers are studying new Apple Inc. AAPL 0.67% measures that they fear will limit access to data about users,...

Didi Sets Valuation Target of $62 Billion to $67 Billion in IPO

June 24, 2021

June 24, 2021

Didi Global Inc., the Beijing-based ride-hailing company, is targeting a valuation of $62 billion to $67 billion in its IPO,...

In Elizabeth Holmes Trial, Ex-Theranos Employees Cite Culture of Fear and Isolation

November 13, 2021

November 13, 2021

In 2013, as Theranos Inc. was in the throes of trying to get its blood-testing machines into a national drugstore...

Fake Covid-19 Vaccines Pose New Threat in Africa

June 6, 2021

June 6, 2021

JOHANNESBURG—On a morning last November, officers from customs and an organized crime unit, backed by two K9 units, raided a...

Jeffrey Toobin Returns to Air on CNN

June 10, 2021

June 10, 2021

Jeffrey Toobin, the former New Yorker staff writer who was fired from the magazine after he was seen masturbating while...

Theranos Founder Elizabeth Holmes’s Emails With Law Firm Allowed at Trial

June 3, 2021

June 3, 2021

A federal judge rejected Theranos Inc. founder Elizabeth Holmes’s request to keep her emails with law firm Boies Schiller Flexner...

Jobless Claims Drop to Another Pandemic Low

June 3, 2021

June 3, 2021

Worker filings for initial jobless claims have dropped by 35% since late April, slipping below 400,000 last week for the...

U.S. Jobless Claims Extend Decline to New Pandemic Low

May 27, 2021

May 27, 2021

Worker filings for jobless benefits fell again to a fresh pandemic low, extending a steady downward trend and adding to...

What a Tech Breakup Could Mean for You

July 3, 2021

July 3, 2021

As momentum builds to curtail the power of Big Tech, lawmakers, Beltway pundits and the companies themselves are all competing...

Facebook Ends Ban on Posts Asserting Covid-19 Was Man-Made

May 27, 2021

May 27, 2021

Facebook Inc. FB -0.04% has ended its ban on posts asserting Covid-19 was man-made or manufactured, a policy shift that...

U.S. Economic Activity Picked Up in Spring, Fed Beige Book Says

June 2, 2021

June 2, 2021

The U.S. economy continued to pick up speed in the spring, as consumers, many of them newly vaccinated and flush...

China Considers Lifting All Childbirth Restrictions by 2025

June 18, 2021

June 18, 2021

SINGAPORE—Chinese officials are drawing up plans to further loosen birth restrictions and transition toward policies that explicitly encourage childbirth, according...

Troubled Companies Take Page From AMC Playbook in Seeking Stock-Market Lifelines

June 20, 2021

June 20, 2021

The frenzied stock-buying activity that may have saved AMC Entertainment Holdings Inc. from bankruptcy is opening up a potential escape...